Neurolysin degrades neurotensin

Stable Identifier
Reaction [transition]
Homo sapiens
Locations in the PathwayBrowser
SVG |   | PPTX  | SBGN
Click the image above or here to open this reaction in the Pathway Browser
The layout of this reaction may differ from that in the pathway view due to the constraints in pathway layout

Neurolysin (NLN, EC is a member of the thermolysin-like mammalian zinc endopeptidase family (Dauch et al. 1995). It is maximally active at neutral pH and responsible for hydrolytic processing of bioactive peptides in the extracellular environment (Shrimpton et al. 2002). It cleaves 3 residues from the C-teminal end of Neurotensin (Dauch et al. 1995). Other endogenous substrates of NLN include bradykinin, angiotensins I and II, substance P, hemopressin, dynorphin A(1–8), metorphamide, and somatostatin (Wangler et al. 2016). The functional significance of NLN is poorly understood (Checler 2014). In vivo studies have linked it to neurotensin-dependent nociception (Vincent et al. 1997), bradykinin-mediated hypotension, microvascular permeability and hyperalgesia (Gomez et al. 2011), and pathogenesis of stroke (Rashid et al. 2014).

Literature References
PubMed ID Title Journal Year
27496565 Preparation and preliminary characterization of recombinant neurolysin for in vivo studies

Bickel, U, Jayaraman, S, Abbruscato, TJ, Mechref, Y, Karamyan, VT, Zhu, R, Wangler, NJ

J. Biotechnol. 2016
3525564 Purification and characterization of a novel neurotensin-degrading peptidase from rat brain synaptic membranes

Kitabgi, P, Vincent, JP, Checler, F

J. Biol. Chem. 1986
Catalyst Activity

metalloendopeptidase activity of NLN [extracellular region]

Orthologous Events
Cite Us!